Logiscreen

Bristol-Myers Squibb Company

$57.27
Market Cap 116.63B
ROE 39.0%
Gross Margin 70.2%
Debt/Equity 2.2
Current Ratio 1.4
Revenue QoQ 2.6%
EPS QoQ 0.1%
F-Score 6

About

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - General

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
15.84
vs median 31.50
P/B
5.74
vs median 2.17
ROE
0.39
vs median 0.09

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics